Back
Brainstorm Cell Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
BCLI
Sponsored
My #1 Coin is...
All the details are on the next page.
Sell
15
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.38
Seasonality Move:
13.57%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Brainstorm Cell Therapeutics Price Quote
$0.38
Brainstorm Cell Therapeutics Key Stats
Sell
15
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Day range:
$0.37 - $0.43
52-week range:
$0.13 - $3.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
539.4K
Avg. volume:
1.2M
1-year change:
-87.66%
Market cap:
$26M
Revenue:
$0
EPS:
$-0.41
How Much Does Brainstorm Cell Therapeutics Make?
Data Unavailable
Is Brainstorm Cell Therapeutics Growing As A Company?
Data Unavailable
Brainstorm Cell Therapeutics Stock Price Performance
-
Did Brainstorm Cell Therapeutics Stock Go Up Last Month?
Brainstorm Cell Therapeutics share price went down by -44.87% last month -
Did BCLI's Share Price Rise Over The Last Year?
BCLI share price fell by -87.66% over the past 1 year
What Is Brainstorm Cell Therapeutics 52-Week High & Low?
-
What Is Brainstorm Cell Therapeutics’s 52-Week High Share Price?
Brainstorm Cell Therapeutics has traded as high as $3.34 over the past 52 weeks -
What Is Brainstorm Cell Therapeutics’s 52-Week Low Share Price?
Brainstorm Cell Therapeutics has traded as low as $0.13 over the past 52 weeks
Brainstorm Cell Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Brainstorm Cell Therapeutics?
-
How Much Debt Does Brainstorm Cell Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Brainstorm Cell Therapeutics Have?
Cash and short term investments quarterly total is $1.3M -
What Is Brainstorm Cell Therapeutics’s Book Value Per Share?
Book value per share is -0.08
Is Brainstorm Cell Therapeutics Cash Flow Positive?
-
What Is BCLI Cash Flow From Operations?
Cash flow from operations (TTM) is -$20.5M -
What Is Brainstorm Cell Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $19M -
What Is Brainstorm Cell Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $2.2M
Brainstorm Cell Therapeutics Return On Invested Capital
Data Unavailable
Brainstorm Cell Therapeutics Earnings Date & Stock Price
-
What Is Brainstorm Cell Therapeutics's Stock Price Today?
A single share of BCLI can be purchased today for 0.38 -
What Is Brainstorm Cell Therapeutics’s Stock Symbol?
Brainstorm Cell Therapeutics trades on the nasdaq under the ticker symbol: BCLI -
When Is Brainstorm Cell Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Brainstorm Cell Therapeutics is scheduled on May 15, 2024 -
When Is BCLI's next ex-dividend date?
Brainstorm Cell Therapeutics's next ex-dividend date is May 5, 2024 -
How To Buy Brainstorm Cell Therapeutics Stock?
You can buy Brainstorm Cell Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Brainstorm Cell Therapeutics Competitors
-
Who Are Brainstorm Cell Therapeutics's Competitors?
Below is a list of companies who compete with Brainstorm Cell Therapeutics or are related in some way:
Brainstorm Cell Therapeutics Dividend Yield
Data Unavailable
Brainstorm Cell Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 9.09% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 2.50 |
Upside from Last Price: | 557.89% |